Jci_page_head_homepage_01 Jci_page_head_homepage_02
Olga Konopatskaya, Karen Gilio, Matthew T. Harper, Yan Zhao, Judith M.E.M. Cosemans, Zubair A. Karim, Sidney W. Whiteheart, Jeffery D. Molkentin, Paul Verkade, Steve P. Watson, Johan W.M. Heemskerk, Alastair W. Poole
Published in Volume 119, Issue 2
J Clin Invest. 2009; 119(2):399–407 doi:10.1172/JCI34665
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 5
Combined pharmacological and genetic approaches reveal redundancy between PKCα and PKCβ for regulation of platelet aggregation.

(A and B) Washed platelets from WT or Prkca–/– mice were pretreated (10 minutes) with the classical PKC isoform inhibitor Gö6976 (1 μM) (A), the PKCβ-selective inhibitor LY333531 (10 μM) (B), or DMSO as vehicle control and stimulated with CRP (5 μg/ml). Aggregation was monitored by turbidimetric aggregometry. Traces shown are representative of 5 independent experiments. (C) Washed platelets from WT or Prkca–/– mice were stimulated with U46619 (U4) (10 μM) and aggregation assessed turbidimetrically. Traces shown are representative of 4 independent experiments.